Market Brief Nov 12, 2026 · 1 min read

$450 million is the number on Intuitive Surgical's Q3 that hospitals and shareholders read very differently.

$450 million is the number on Intuitive Surgical's Q3 that hospitals and shareholders read very differently.

$450 million is the number on Intuitive Surgical's Q3 that hospitals and shareholders read very differently. My read is that the charge hit reported profit for one quarter while demand kept running, and those are two separate stories.

  • The $450M is an agreement to settle a hospital class action over third-party repair and remanufacturing of da Vinci systems and instruments, plus injunctive relief. It still needs court approval, and management said a decision isn't expected until 2027.
  • Q3 2026, reported October 20: revenue up 22% to $3.05B, total procedures up 15%.
  • GAAP EPS fell to $1.49 from $1.95, with the company pointing partly to the litigation charge. Adjusted EPS rose 25% to $3.00. I usually distrust adjusted numbers, but here the gap traces to one named charge.
  • Full-year 2026 da Vinci procedure growth guidance was narrowed to 14%-15%. Hospitals keep using the robots, and the settlement's repair terms may matter to them as much as the cash.

$ISRG was at $452.79 pre-market on Nov. 12, up 0.73% from a $449.53 close, so the market isn't treating this as a demand problem. If procedure growth holds that 14%-15% range, I see a one-time hit, though I could be wrong if the court process drags out longer than expected.

Source:
Zacks: https://www.zacks.com/stock/news/3028324/isrg-agrees-to-450m-settlement-what-does-it-mean-for-investors

Not financial advice. For informational and educational purposes only.

Track your live portfolio alongside our daily institutional research

Connect your brokerage in 60 seconds and get full access to Position Tracker Substack research inside your dashboard.

Start your free trial →